Literature DB >> 1975317

Response to doxorubicin/methotrexate/fluorouracil in advanced adenocarcinoma of pancreas or biliary tract.

S Pyrhönen, M Valtonen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 1975317     DOI： 10.1016/0140-6736(90)91652-q

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  2 in total

1.  Acetazolamide for alkalinisation of urine in patients receiving high-dose methotrexate.

Authors:  J Shamash; H Earl; R Souhami
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

2.  Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer.

Authors:  S Pyrhönen; T Kuitunen; P Nyandoto; M Kouri
Journal:  Br J Cancer       Date:  1995-03       Impact factor: 7.640
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.